Health CareHealth Care Equipment & Services
  • Price (USD)209.57
  • Today's Change-1.45 / -0.69%
  • Shares traded391.41k
  • 1 Year change44.28%
  • Beta0.3231
Data delayed at least 15 minutes, as of Nov 23 2020 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

  • Revenue in USD (TTM)3.03bn
  • Net income in USD679.90m
  • Incorporated1994
  • Employees7.77k
  • Location
    Resmed Inc9001 Spectrum Center BlvdSAN DIEGO 92123-1438United StatesUSA
  • Phone+1 (858) 746-2400
  • Fax+1 (302) 636-5454
  • Websitehttps://www.resmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Varian Medical Systems, Inc.3.17bn273.00m15.83bn10.06k58.277.6359.415.002.982.9434.6122.770.73953.352.91--6.387.9911.3814.2843.4742.968.6210.161.12--0.1455---1.764.93-8.96-2.68----
Steris PLC3.02bn422.29m16.62bn13.00k39.524.5526.555.504.934.9335.2642.780.56616.645.94232,485.807.904.978.625.4443.3841.4813.969.092.0017.680.217941.258.9410.3734.0624.7220.2710.01
Teleflex Incorporated2.51bn367.01m17.34bn14.40k47.935.3629.336.917.777.7853.0569.500.38962.346.37174,092.305.705.516.196.1853.4455.1014.6412.851.888.260.396721.636.007.12135.1919.408.730.00
Insulet Corporation867.69m28.87m17.42bn1.35k604.1829.25257.3820.080.43740.437413.389.030.58252.9010.65642,736.301.94-3.142.15-3.6264.0061.423.33-4.195.911.940.6077--30.9326.12252.37--71.60--
Cooper Companies Inc2.44bn272.40m17.72bn12.00k60.724.3432.057.265.475.5949.1176.580.37781.605.71203,408.304.226.605.007.4464.1563.1111.1615.050.64367.260.33340.87774.769.0930.0111.304.180.00
Hologic, Inc.3.78bn1.12bn17.99bn5.81k16.656.6612.104.764.204.2014.2710.510.55383.634.50649,535.6016.294.2319.615.1359.6754.6629.419.481.4710.250.53040.0012.156.90661.5353.3311.84--
West Pharmaceutical Services Inc.2.04bn311.70m20.79bn8.20k68.2312.0951.7310.204.124.1226.9423.260.85665.055.91248,451.2012.409.4814.8511.2034.8532.4914.4810.892.11--0.129521.647.135.3018.2513.722.438.27
Zimmer Biomet Holdings Inc7.06bn-151.90m30.37bn19.90k--2.5634.854.30-0.7559-0.755934.0657.270.29230.875.67355,020.10-0.61981.45-0.70841.6070.1170.72-2.124.691.179.170.41153.740.621511.30405.109.4616.051.76
ResMed Inc.3.03bn679.90m30.69bn7.77k45.4411.4536.7010.134.664.6620.7618.490.69013.036.20389,691.1015.5012.6217.8114.7558.2957.7122.4518.461.8015.530.282845.4413.4411.9951.4111.998.056.85
DexCom, Inc.1.82bn231.10m31.75bn3.90k136.8821.17108.7017.442.422.4219.0015.620.6053.826.02466,820.507.68-1.968.91-2.3166.3265.6512.69-
Align Technology, Inc.2.29bn1.74bn34.80bn14.53k20.0711.4719.0315.2221.9921.9928.9438.470.67616.083.95157,412.8051.3818.6072.8226.4171.0474.1675.9919.471.20--0.000.0022.3925.8710.6324.8744.10--
Baxter International Inc11.53bn733.00m40.29bn50.00k55.974.7025.813.491.411.7622.4216.770.61673.676.05230,620.003.979.524.7411.9941.1242.296.4316.392.0613.440.429924.492.371.17-40.0012.04-18.18-16.14
Data as of Nov 23 2020. Currency figures normalised to Resmed Inc's reporting currency: US Dollar USD

Institutional shareholders

40.34%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202014.97m10.33%
BlackRock Fund Advisorsas of 30 Sep 20208.71m6.01%
WCM Investment Management LLCas of 30 Sep 20208.69m6.00%
SSgA Funds Management, Inc.as of 30 Sep 20206.59m4.55%
Capital Research & Management Co. (World Investors)as of 30 Sep 20205.34m3.68%
Fidelity Management & Research Co. LLCas of 30 Sep 20204.37m3.02%
Baillie Gifford & Co.as of 30 Sep 20203.13m2.16%
Geode Capital Management LLCas of 30 Sep 20202.48m1.71%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20202.25m1.55%
Invesco Advisers, Inc.as of 30 Sep 20201.91m1.32%
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.